Insulet Corporation ($PODD) Stock Forecast: Down 5.1% Today

What is Insulet Corporation?

Insulet Corporation (PODD) is a company known for its Omnipod Insulin Management System. The stock had a strong bearish movement today.

Why is Insulet Corporation going down?

PODD stock is down 5.1% on Jan 23, 2026 17:50

• Insulet Corporation (PODD) had a bearish movement possibly due to the following reasons:
• Despite surpassing EPS estimates, the company missed revenue expectations, which might have disappointed investors.
• The significant reduction in stake by SG Americas Securities LLC could have signaled a lack of confidence in the company's future performance.
• The appointment of a new CEO at BVI, who was the former CEO of Insulet, might have raised concerns about leadership stability at Insulet.
• Although Stephens Investment Management Group LLC increased its stake, the overall market sentiment could have been influenced by the mixed signals from institutional investors.

PODD Price Chart

PODD Technical Analysis

PODD News

What You Need To Know Ahead of Insulet’s Earnings Release

Insulet Corporation (PODD), known for its Omnipod Insulin Management System, is set to release its Q4 fiscal 2025 earnings. Analysts anticipate a 28.7% year-over-year profit growth to $1.48 per share. Despite underperforming the broader market and its sector recently, Wall Street maintains a "Strong Buy" consensus rating for Insulet, projecting significant upside from current levels based on a mean price target of $376.42.

https://www.inkl.com/news/what-you-need-to-know-ahead-of-insulet-s-earnings-release

BVI appoints Jim Hollingshead as CEO

BVI, an ophthalmic device company, has appointed Jim Hollingshead, former CEO of Insulet, as its new President and CEO. Hollingshead will lead BVI's global eye care business, leveraging a recent $1 billion financing round to accelerate product innovation and expand its global footprint. He replaces Shervin Korangy, who will now serve as an adviser to BVI and senior adviser to TPG Capital, BVI's private equity owner.

https://www.medtechdive.com/news/bvi-appoints-jim-hollingshead-as-ceo/810066/

SG Americas Securities LLC Has $831,000 Stock Holdings in Insulet Corporation $PODD

SG Americas Securities LLC significantly reduced its stake in Insulet Corporation (NASDAQ:PODD) by 91.2% in the third quarter of 2025, selling over 27,000 shares and retaining a holding valued at $831,000. Insulet recently surpassed EPS estimates with $1.24 reported earnings but missed revenue expectations, though its revenue grew 29.9% year-over-year. Despite the reduced institutional holding, analysts are largely positive on PODD, with a "Moderate Buy" rating and an average target price of $379.10.

https://www.marketbeat.com/instant-alerts/filing-sg-americas-securities-llc-has-831000-stock-holdings-in-insulet-corporation-podd-2026-01-21/

Insulet Corporation $PODD Shares Purchased by Stephens Investment Management Group LLC

Stephens Investment Management Group LLC increased its stake in Insulet Corporation (NASDAQ:PODD) by 5.2% during the third quarter, acquiring an additional 6,971 shares. Several other institutional investors also made significant moves, with Norges Bank opening a large new position and Munro Partners significantly boosting its holdings. Despite missing revenue forecasts, Insulet beat EPS expectations and maintains a "Moderate Buy" consensus rating from analysts.

https://www.marketbeat.com/instant-alerts/filing-insulet-corporation-podd-shares-purchased-by-stephens-investment-management-group-llc-2026-01-17/

Trending Today

MicroVision Inc. ($MVIS) Stock Forecast: Down 5.6% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Down 5.4% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Down 5.4% Today

Etsy Inc. ($ETSY) Stock Forecast: Down 5.3% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Up 6.0% Today

Intellia Therapeutics, Inc. ($NTLA) Stock Forecast: Down 6.9% Today

DXC Technology Company ($DXC) Stock Forecast: Down 8.1% Today

Robert Half Inc. ($RHI) Stock Forecast: Up 18.6% Today

Air Products and Chemicals Inc. ($APD) Stock Forecast: Up 5.5% Today

Alcoa Corporation ($AA) Stock Forecast: Down 5.6% Today

Insulet Corporation Price History

09.04.2025 - PODD Stock was up 14.4%

• Exceeded earnings and revenue expectations for Q1, indicating strong financial performance.
• The positive surprise in earnings and revenues suggests that the company's insulin delivery systems are in high demand.
• Investors may be optimistic about the future prospects of Insulet (PODD) based on these strong financial results.
• The bullish movement in the stock price could be attributed to the market's positive reaction to the company's impressive performance in Q1.

24.03.2025 - PODD Stock was up 5.2%

• Insulet (PODD) has delivered impressive performance over the last 15 years, consistently outperforming the market by 10.59% on an annual basis with an average return of 21.0%.
• The stock's upward movement today could be linked to Insulet's sustained growth and solid market capitalization of $17.14 billion.
• Investor optimism regarding Insulet's future within the medical device sector may have heightened, resulting in increased buying activity and pushing the stock price upwards.

07.07.2025 - PODD Stock was up 9.2%

• Insulet (PODD) stock experienced a strong bullish movement today, possibly driven by positive market sentiment and investor optimism.
• The anticipation of strong Q2 performance and earnings growth expectations by financial analysts could have contributed to the bullish momentum.
• The long-term outperformance of Insulet stock over the past decade, with an average annual return of 23.62%, may have attracted investors seeking growth opportunities.
• Overall, the combination of positive market expectations, strong historical performance, and an upcoming earnings report could have fueled the bullish movement in Insulet (PODD) stock today.

07.07.2025 - PODD Stock was up 5.7%

• In Q2, Insulet (PODD) surpassed both earnings and revenue forecasts, demonstrating robust financial performance.
• The stock has consistently outperformed the market over the last ten years, with a notable average annual return, indicating a reliable performance history.
• The stock's price increase today is likely influenced by the favorable quarterly results and sustained market outperformance.
• Investors show confidence in Insulet's growth potential, backed by its strong financial performance and market positioning in the diabetes management sector.

25.01.2025 - PODD Stock was down 5.9%

• Despite posting strong Q4 earnings and revenues exceeding expectations, Insulet Corporation (PODD) saw a downtrend in its stock price.
• Profit-taking by investors following a robust performance may have triggered the negative market response, causing a temporary decline.
• Concerns about future growth potential or external economic factors affecting the healthcare sector could have spurred the selling pressure on Insulet's stock.
• Shifts in market sentiment possibly driven by factors beyond the company's performance, such as overall market trends or geopolitical events, may have contributed to today's bearish movement in PODD stock.

23.00.2026 - PODD Stock was down 5.1%

• Insulet Corporation (PODD) had a bearish movement possibly due to the following reasons:
• Despite surpassing EPS estimates, the company missed revenue expectations, which might have disappointed investors.
• The significant reduction in stake by SG Americas Securities LLC could have signaled a lack of confidence in the company's future performance.
• The appointment of a new CEO at BVI, who was the former CEO of Insulet, might have raised concerns about leadership stability at Insulet.
• Although Stephens Investment Management Group LLC increased its stake, the overall market sentiment could have been influenced by the mixed signals from institutional investors.

06.10.2025 - PODD Stock was down 5.7%

• Increased short interest in Insulet Corp (PODD) potentially contributed to the bearish movement.
• Wall Street estimates for key metrics ahead of Insulet's Q3 earnings may have fallen short, affecting investor sentiment.
• The overall market performance and potential profit-taking activities likely influenced the bearish movement in Insulet's stock.
• Investors might be reacting to current market conditions and short-term factors impacting Insulet's stock price negatively, despite its historical outperformance.

20.10.2025 - PODD Stock was down 2.0%

• Today's decline in Insulet's stock could be linked to profit-taking following a sustained period of impressive performance.
• An uptick in activity from options traders may have contributed to increased volatility and selling activity in the stock.
• Despite the recent setback, positive earnings estimate revisions indicate that Insulet is positioned favorably for a potential upswing in the near term.

20.10.2025 - PODD Stock was down 6.2%

• The growing short interest could be influencing the stock's decline as more investors are taking positions against the company.
• Despite Insulet's strong performance in the past 15 years, it seems insufficient to counter the prevailing negative market sentiment, resulting in a drop in the stock price.
• Activities in the options market indicate potential insider information or speculative trading affecting the stock, intensifying the bearish outlook.

08.07.2025 - PODD Stock was up 5.7%

• Insulet (PODD) posted robust Q2 results, surpassing revenue projections and revising its annual sales forecast upwards. This strong financial showing likely bolstered investor confidence in the company's growth potential, contributing to the stock's favorable performance.
• The company's consistent outperformance over the past ten years, as noted in insights on its historical stock returns, may have also enticed investors looking for sustainable growth opportunities.
• The market's optimistic response to Insulet's earnings beat and raised guidance indicates confidence in the adoption of its insulin pump products, especially the Omnipod 5, pointing towards a promising future performance for the company.

29.03.2025 - PODD Stock was down 5.4%

• The decrease in Insulet's stock (PODD) value is possibly linked to a recent downgrade by a prominent Wall Street analyst, triggering a change in market sentiment.
• Despite its track record of strong performance and consistent annual returns, investors seem to be responding to the recent rating downgrade and repositioning their investments.
• With a market capitalization of $17.14 billion, Insulet holds a substantial position in the medical device sector. However, current influences like analyst evaluations can still impact its stock performance in the short term.

01.09.2025 - PODD Stock was down 5.8%

• Despite today's decline, Insulet Inc. (PODD) has witnessed a notable 37.4% increase in its stock value in the last year.
• The current decrease in stock price may be linked to investors taking profits following a sustained growth period.
• Key drivers like the introduction of Omnipod 5, global expansion, and enhanced presence in diabetes care have fueled the stock's upward movement in the past year.
• Investors could be reconsidering their positions in PODD stock, contributing to the recent bearish trend, possibly influenced by a wider market adjustment or sector repositioning.